{"component": "definition", "props": {"groups": [{"samples": [{"hash": "jUDfo2MwbGp", "uri": "/contracts/jUDfo2MwbGp#salix", "label": "Manufacturing and Supply Agreement", "score": 31.340862423, "published": true}, {"hash": "3IyGigIRrq6", "uri": "/contracts/3IyGigIRrq6#salix", "label": "Confidentiality Agreement (RedHill Biopharma Ltd.)", "score": 26.1526351814, "published": true}, {"hash": "3m2FtOFHW7j", "uri": "/contracts/3m2FtOFHW7j#salix", "label": "Merger Agreement (Salix Pharmaceuticals LTD)", "score": 25.5174537988, "published": true}], "snippet": "has the meaning set forth in the preamble hereto.", "size": 11, "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [29, 41]}], "hash": "8bccce1d0361cba936f9f507ba47a5ce", "id": 1}, {"samples": [{"hash": "89SeJM60pHY", "uri": "/contracts/89SeJM60pHY#salix", "label": "Co Promotion Agreement", "score": 31.340862423, "published": true}, {"hash": "iovsuYuBvzJ", "uri": "/contracts/iovsuYuBvzJ#salix", "label": "Co Promotion Agreement (Salix Pharmaceuticals LTD)", "score": 21.0, "published": true}, {"hash": "1ocGOfWIWnA", "uri": "/contracts/1ocGOfWIWnA#salix", "label": "Co Promotion Agreement (Salix Pharmaceuticals LTD)", "score": 21.0, "published": true}], "snippet": "means Salix Pharmaceuticals, Inc., a California corporation.", "size": 7, "snippet_links": [{"key": "california-corporation", "type": "clause", "offset": [37, 59]}], "hash": "e7efbadf1fc34bc3515781ad843e944d", "id": 2}, {"samples": [{"hash": "f2kItRraHkT", "uri": "/contracts/f2kItRraHkT#salix", "label": "License Agreement (Salix Pharmaceuticals LTD)", "score": 19.0, "published": true}, {"hash": "bFGNln0P4Wz", "uri": "/contracts/bFGNln0P4Wz#salix", "label": "License Agreement (Salix Pharmaceuticals LTD)", "score": 19.0, "published": true}], "snippet": "means Salix Pharmaceuticals, Inc., a company incorporated under the laws of California having its principal place of business at \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587, a Glycyx Affiliate.", "size": 5, "snippet_links": [{"key": "laws-of-california", "type": "clause", "offset": [68, 86]}, {"key": "principal-place-of-business", "type": "clause", "offset": [98, 125]}], "hash": "f4b73789a46e5eb2a48ec893a3b3fd91", "id": 3}, {"samples": [{"hash": "fpPL04KcSxL", "uri": "/contracts/fpPL04KcSxL#salix", "label": "License Agreement (Salix Pharmaceuticals LTD)", "score": 22.3524982888, "published": true}, {"hash": "4yFpIlZZSvA", "uri": "/contracts/4yFpIlZZSvA#salix", "label": "Development, Commercialization and License Agreement (Salix Pharmaceuticals LTD)", "score": 22.3524982888, "published": true}, {"hash": "3Pajk7J8cRE", "uri": "/contracts/3Pajk7J8cRE#salix", "label": "License Agreement (Progenics Pharmaceuticals Inc)", "score": 22.3524982888, "published": true}], "snippet": "has the meaning set forth in the first paragraph hereof.", "size": 3, "snippet_links": [{"key": "first-paragraph", "type": "definition", "offset": [33, 48]}], "hash": "34537e72c2dcd584877ec478bda94971", "id": 4}, {"samples": [{"hash": "9YbWCxbSkHk", "uri": "https://www.sec.gov/Archives/edgar/data/1585608/000104746917004307/a2232537zex-10_63.htm", "label": "Bill of Sale (Jaguar Animal Health, Inc.)", "score": 19.4880219028, "published": false}, {"hash": "4ukh9iclxWm", "uri": "https://www.sec.gov/Archives/edgar/data/1585608/000104746917003695/a2232030zex-10_63.htm", "label": "Transfer and Transition Agreement (Jaguar Animal Health, Inc.)", "score": 19.3976728268, "published": false}], "snippet": "has the meaning assigned to such term in the Preliminary Statements.", "size": 2, "snippet_links": [{"key": "preliminary-statements", "type": "clause", "offset": [45, 67]}], "hash": "30211e4354a7df84b46ac7f08e9a96e2", "id": 5}, {"samples": [{"hash": "5uVyxWRWJ63", "uri": "/contracts/5uVyxWRWJ63#salix", "label": "Development and License Agreement", "score": 31.340862423, "published": true}, {"hash": "cWTY4GECM2x", "uri": "/contracts/cWTY4GECM2x#salix", "label": "Development and License Agreement (Salix Pharmaceuticals LTD)", "score": 21.0, "published": true}], "snippet": "means Salix Pharmaceuticals, Inc., as set forth in the first paragraph of this Agreement.", "size": 2, "snippet_links": [{"key": "first-paragraph", "type": "definition", "offset": [55, 70]}, {"key": "this-agreement", "type": "clause", "offset": [74, 88]}], "hash": "abdd3a8b136620c9f7ea845591f1a1da", "id": 6}, {"samples": [{"hash": "gYNtwf2KibO", "uri": "/contracts/gYNtwf2KibO#salix", "label": "License Agreement (Salix Pharmaceuticals LTD)", "score": 22.1608487337, "published": true}], "snippet": "and \u201cSalix\u201d shall substituted for \u201cPhotocure\u201d in respect of prosecution of any Joint Patent that relates to or covers the HAL Active Ingredient or Lumacan Products) , 9.4 (only as it relates to Joint Patents, but, if the termination of this Agreement is by Photocure under Section 14.2 or 14.3 or by Salix under Section 14.5, then \u201cPhotocure\u201d shall substituted for \u201cSalix\u201d and \u201cSalix\u201d shall substituted for \u201cPhotocure\u201d in respect of enforcement of any Joint Patent that does not relate to or cover a product then marketed or in development by Salix or its Affiliates or licensees), 12.1, 12.3, 12.5, 12.6, 12.7, Article 13, this Article 14, Sections 15.1, 15.3, 15.4, 15.5, 15.6, 15.7, 15.8, 15.9, 15.11, 15.12, 15.13, 15.14, 15.15, 15.16, 15.17, 15.18, 15.19, 15.21, and 15.23 and, to the extent required to give effect to the following provisions, Article 1. Except as otherwise provided in Section 14.6(c) and this Section 14.12, all rights and obligations of the Parties under this Agreement shall terminate upon expiration or termination of this Agreement for any reason.", "size": 2, "snippet_links": [{"key": "in-respect-of", "type": "clause", "offset": [46, 59]}, {"key": "relates-to", "type": "definition", "offset": [97, 107]}, {"key": "active-ingredient", "type": "definition", "offset": [126, 143]}, {"key": "joint-patents", "type": "clause", "offset": [194, 207]}, {"key": "the-termination", "type": "clause", "offset": [217, 232]}, {"key": "section-142", "type": "clause", "offset": [273, 285]}, {"key": "by-salix", "type": "clause", "offset": [297, 305]}, {"key": "section-145", "type": "clause", "offset": [312, 324]}, {"key": "enforcement-of", "type": "clause", "offset": [433, 447]}, {"key": "relate-to", "type": "definition", "offset": [479, 488]}, {"key": "in-development", "type": "definition", "offset": [525, 539]}, {"key": "article-13", "type": "definition", "offset": [612, 622]}, {"key": "article-14", "type": "definition", "offset": [629, 639]}, {"key": "to-the-extent", "type": "clause", "offset": [783, 796]}, {"key": "give-effect-to", "type": "definition", "offset": [809, 823]}, {"key": "except-as-otherwise-provided", "type": "clause", "offset": [861, 889]}, {"key": "rights-and-obligations-of-the-parties", "type": "clause", "offset": [937, 974]}, {"key": "for-any-reason", "type": "clause", "offset": [1061, 1075]}], "hash": "ee2548f670c36c661ab50903a9809910", "id": 7}, {"samples": [{"hash": "gYNtwf2KibO", "uri": "/contracts/gYNtwf2KibO#salix", "label": "License Agreement (Salix Pharmaceuticals LTD)", "score": 22.1608487337, "published": true}], "snippet": "and \u201cSalix\u201d shall substituted for \u201cPhotocure\u201d in respect of enforcement of any Joint Patent that does not relate to or cover a product then marketed or in development by Salix or its Affiliates or licensees), 12.1, 12.3, 12.5, 12.6, 12.7, Article 13, this Article 14, Sections 15.1, 15.3, 15.4, 15.5, 15.6, 15.7, 15.8, 15.9, 15.11, 15.12, 15.13, 15.14, 15.15, 15.16, 15.17, 15.18, 15.19, 15.21, and 15.23 and, to the extent required to give effect to the following provisions, Article 1. Except as otherwise provided in Section 14.6(c) and this Section 14.12, all rights and obligations of the Parties under this Agreement shall terminate upon expiration or termination of this Agreement for any reason.", "size": 2, "snippet_links": [{"key": "in-respect-of", "type": "clause", "offset": [46, 59]}, {"key": "enforcement-of", "type": "clause", "offset": [60, 74]}, {"key": "joint-patent", "type": "definition", "offset": [79, 91]}, {"key": "relate-to", "type": "definition", "offset": [106, 115]}, {"key": "in-development", "type": "definition", "offset": [152, 166]}, {"key": "by-salix", "type": "clause", "offset": [167, 175]}, {"key": "article-13", "type": "definition", "offset": [239, 249]}, {"key": "article-14", "type": "definition", "offset": [256, 266]}, {"key": "to-the-extent", "type": "clause", "offset": [410, 423]}, {"key": "give-effect-to", "type": "definition", "offset": [436, 450]}, {"key": "except-as-otherwise-provided", "type": "clause", "offset": [488, 516]}, {"key": "rights-and-obligations-of-the-parties", "type": "clause", "offset": [564, 601]}, {"key": "for-any-reason", "type": "clause", "offset": [688, 702]}], "hash": "b7a12966e04cac367f267317f0967fc4", "id": 8}, {"samples": [{"hash": "4rEIiPiZmse", "uri": "/contracts/4rEIiPiZmse#salix", "label": "Agreement (Salix Pharmaceuticals LTD)", "score": 18.0, "published": true}], "snippet": "means Salix Pharmaceuticals, Inc a company incorporated under the laws of California, whose registered office is at 3600 W. Bayshore Road, Suite 205, Palo Alto, Californi\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587, \u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.", "size": 1, "snippet_links": [{"key": "laws-of-california", "type": "clause", "offset": [66, 84]}, {"key": "registered-office", "type": "clause", "offset": [92, 109]}, {"key": "palo-alto", "type": "clause", "offset": [150, 159]}], "hash": "990fe072f271c9b9902e4767d8111707", "id": 9}, {"samples": [{"hash": "5WIzrYuBTob", "uri": "http://pdf.secdatabase.com/2910/0000950144-03-000568.pdf", "label": "pdf.secdatabase.com", "score": 19.28379672, "published": false}], "snippet": "means Salix Ventures II, L.P. and Salix Affiliates II, L.P., collectively.", "size": 1, "snippet_links": [], "hash": "611da0f87d8cd58cf5fb85724cc39194", "id": 10}], "next_curs": "ClISTGoVc35sYXdpbnNpZGVyY29udHJhY3Rzci4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIOc2FsaXgjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "has the meaning set forth in the preamble hereto.", "size": 39, "title": "Salix", "id": "salix", "examples": ["For clarity, any sublicense agreement entered into by <strong>Salix</strong> with any of its Affiliates shall terminate upon the termination of this Agreement.", "<strong>Salix</strong> shall provide Altana with a copy of the results of each audit promptly after such results become available.", "The contact information for the Medical Call Center for <strong>Salix</strong> and <strong>Salix</strong>\u2019s Associate Director, Quality are as set forth in Appendix E, as may be updated from time to time by <strong>Salix</strong> with prior written notice to Altana.", "<strong>Salix</strong> Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases.", "During the course of any such examination, <strong>Salix</strong> or its third party designee shall not disrupt or otherwise interfere with the business of Altana.", "All Compound shall be labeled in accordance with Applicable Law and packed for shipping in accordance with packing instructions provided by <strong>Salix</strong>.", "<strong>Salix</strong> shall invoice Cosmo from time to time for such packaging and labeling costs, and Cosmo shall pay such invoices within thirty (30) days.", "<strong>Salix</strong> shall be the sole owner of this master drug safety database.", "All notices, requests and other communications hereunder must be in writing, specifically reference this Agreement in a prominent manner, and be delivered personally or by recognized international courier to the Parties at the following addresses: If to <strong>Salix</strong> to: <strong>Salix</strong> Pharmaceuticals, Inc.", "<strong>Salix</strong> shall have the right to offset any such costs against any payments owed by <strong>Salix</strong> to Lupin under this Agreement."], "related": [["pfizer", "Pfizer", "Pfizer"], ["abbott", "Abbott", "Abbott"], ["novartis", "Novartis", "Novartis"], ["bms", "BMS", "BMS"], ["shire", "Shire", "Shire"]], "related_snippets": [], "updated": "2025-07-07T00:16:55+00:00"}, "json": true, "cursor": ""}}